4.6 Article

The Patient Simple Clinical Colitis Activity Index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: A comparison of the P-SCCAI with clinician-based SCCAI and biological markers

期刊

JOURNAL OF CROHNS & COLITIS
卷 7, 期 11, 页码 890-900

出版社

OXFORD UNIV PRESS
DOI: 10.1016/j.crohns.2012.11.007

关键词

Inflammatory bowel disease; Ulcerative colitis; Disease activity; Validation; Simple Clinical Colitis; Activity Index

资金

  1. Scheringh and Plough

向作者/读者索取更多资源

Aim: To develop a patient-based Simple Clinical Colitis Activity Index (P-SCCAI) of ulcerative colitis (UC) activity and to compare it with the clinician-based SCCAI, C-reactive protein (CRP) and Physician's Global Assessment (PGA) of UC activity. Monitoring UC activity may give patients disease control and prevent unnecessary examinations. Methods: Consecutive UC patients randomly completed the P-SCCAI either before or after consultation. Gastroenterologists assessed patients' UC activity on the same day. Overall agreement between SCCAI and P-SCCAI was calculated with Spearman's Rho and Mann Whitney U test. Agreement regarding active disease versus remission and agreement at domain level were calculated by percent agreement and kappa (lc). Results: 149 (response rate 84.7%) UC patients participated. P-SCCAI and SCCAI showed a large correlation (rs= 0.79). The medians (IQR) of the P-SCCAI (3.78;0-15) tended to be higher than those of the SCCAI (2.86;0-13), although this difference did not reach statistical significance (z= 1.711 p =0.088). In 77% of the cases the difference between clinicians and patients' scores was not clinically different (i.e. 2). Percentage agreement between clinicians and patients, judging UC as active or in remission, was 87%, rs = 0.66, tc=0.66, indicating a substantial agreement. In general patients tended to report more physical symptoms than clinicians. C-Reactive protein (CRP) was found to have a significant association with both P-SCCAI and SCCAI (K=0.32, K=0.39 respectively) as was PGA (K=0.73 for both indices). Conclusions: The P-SCCAI is a promising tool given its substantial agreement with the SCCAI and its feasibility. Therefore, P-SCCAI can complement SCCAI in clinical care and research. (C) 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据